Research Payment definition

Research Payment means the [***] amount of [***].
Sample 1Sample 2
Research Payment means [ ] pounds (£[ ]).
Sample 1Sample 2
Research Payment. - means - is defined in Section 2.1 .
Sample 1

Examples of Research Payment in a sentence

  • The Firm conducted testing against its Compliance Manual, including its Order Execution Policy, Code of Ethics, Conflicts Mitigation Policy and Policy on Research and Use of Research Payment Accounts during the period and had no material findings.

  • The payments from the Research Payment Account are not linked to the volume or the value of transactions executed on behalf of a Fund.

  • If at the end of the year the Research Payment Account is in surplus, any such surplus may be rebated to the Funds proportionately or off-set against the budgeted amount for research and the Research Charge applicable during the following annual reporting period.

  • As far as such additional services by brokers are to be compensated, they can either be paid by the Management Company or the Investment Manager from their own funds or via a separate account, a so-called Research Payment Account ("RPA").

  • Research Payment Account Aperture UK, in its capacity as Investment Manager will utilise a RPA to pay for research as permitted under MiFID II and ESMA rules, for each Sub-fund for which it acts as Investment Manager listed in Appendix A, unless otherwise provided in Appendix A for a specific Sub-fund.

  • Amounts collected will be paid monthly into a Research Payment Account which will only be used for the purchase of third party research.

  • The Research Payment Account will be controlled by the Investment Manager and established in accordance with the FCA Rules.

  • Collected monies on the RCA are periodically transferred to the Research Payment Account (RPA) held by the Manager.

  • The relevant Research Payment Account will be funded by budgeted research charges which, unless otherwise stated in the relevant Supplement, shall include but not be limited to the operating expenses related to researching, implementing, carrying out and disposing of specialised, specific investment research for the particular Fund and amounts payable to third party consultants (“Research Charges”) paid by the relevant Fund out of its own assets.

  • Research Payment Account The ACD and Investment Manager have arranged for the creation of a Research Payment Account on behalf of the Company to take effect from 3 December 2018.


More Definitions of Research Payment

Research Payment means the [***] amount of [***]. 1.82 “Research Plan” means the initial research plan attached to this Agreement as Exhibit A, as it may be amended from time to time in
Sample 1
Research Payment means a payment of [***] per FTE per year.
Sample 1
Research Payment means the [***] amount of [***]. Portions of this exhibit, indicated by the xxxx “[***],” have been redacted pursuant to a confidential treatment request. An unredacted version of this exhibit has been filed separately with the Commission.
Sample 1
Research Payment means - is defined in Section 2.1.
Sample 1

Related to Research Payment

  • Research Program Term has the meaning set forth in Section 2.2.

  • Sublicense Fees shall have the meaning set forth in Section 7.3 below.

  • Development Milestone Payment shall have the meaning set forth in Section 9.2(a).

  • Research Period means the research period as described in the Commissioned Research Plan. In accordance with the provisions of this Agreement, in the event that the Agreement ended prior to the completion date of the research originally set, the date the Agreement ends shall be read as the research period.

  • Milestone Payment means a payment identified in the Implementation Plan to be made following the issue of a Satisfaction Certificate in respect of Achievement of the relevant Milestone;

  • Research Program has the meaning set forth in Section 2.1.

  • Research Project means a discrete scientific endeavor to answer a research question or a set of research questions related to medical marijuana and is required for a medical marijuana research license.

  • Research Plan shall have the meaning set forth in Section 2.1.

  • Milestone Payments has the meaning set forth in Section 4.2.

  • License Fees means the license fees, including all taxes thereon, paid or required to be paid by Licensee for the license granted under this Agreement.

  • Research Term has the meaning set forth in Section 3.2.

  • Sales Milestone Payment shall have the meaning set forth in Section 8.4.

  • Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;

  • Collaborating physician means the physician who,

  • Collaboration Term has the meaning set forth in Section 2.2.

  • Development Fee means a fee for the packaging of a Property, including negotiating and approving plans, and undertaking to assist in obtaining zoning and necessary variances and necessary financing for the Property, either initially or at a later date.

  • License Fee means the amount payable by the licensee to DMRC as per rates offered by the Selected Bidder for utilization of licensed space and accepted by DMRC to be paid by the Licensee along with other charges and any kind of Central or State Taxes, local levies, statutory dues, etc. that may be payable by the licensee as per prevalent law.

  • Collaboration Know-How means all Know-How conceived, discovered, developed or otherwise made by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing (solely or jointly by or on behalf of a particular Party or any of its Affiliates or permitted subcontractors of any of the foregoing) in the course of [***].

  • Collaboration has the meaning set forth in Section 2.1.

  • Research Use shall have the meaning given in Section 2.2.2 of this Agreement.

  • Research License means a nontransferable, nonexclusive license to make and to use the Licensed Products or the Licensed Processes as defined by the Licensed Patent Rights for purposes of research and not for purposes of commercial manufacture or distribution or in lieu of purchase.

  • Milestone Payment Date has the meaning set forth in Section 2.4(a).

  • Development Expenses means, with respect to SAIL Developments as well as HOME Developments when the HOME Development is also at least partially financed with a MMRB Loan (as defined in rule Chapter 67-21, F.A.C.), usual and customary operating and financial costs, such as the compliance monitoring fee, the financial monitoring fee, replacement reserves, the servicing fee and the debt service reserves. As it relates to SAIL Developments as well as HOME Developments when the HOME Development is also at least partially financed with a MMRB Loan (as defined in rule Chapter 67-21, F.A.C.) and to the application of Development Cash Flow described in subsections 67-48.010(5) and (6), F.A.C., as it relates to SAIL Developments or in paragraph 67-48.020(3)(b), F.A.C., as it relates to HOME Developments, the term includes only those expenses disclosed in the operating pro forma on an annual basis included in the final credit underwriting report, as approved by the Board, and maximum of 20 percent Developer Fee per year.

  • Development Fees means fees imposed to offset capital costs of providing public infrastructure, public safety or other public services to a development and authorized pursuant to A.R.S. Section 9-463.05, A.R.S. Section 11-1102 or A.R.S. Title 48 regardless of the jurisdiction to which the fees are paid.

  • Development Activities means those activities which are normally undertaken for the development, construction, repair, renovation, rehabilitation or conversion of buildings for residential purposes, including the acquisition of property;

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).